Transcripts

Praxis Precision Medicines (PRAX) earnings call transcripts

Earnings call transcripts for Praxis Precision Medicines, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the quarter as the transition from development to launch execution, while emphasizing regulatory progress and a disciplined pause on FDA updates.

    Aug 06, 2026Confident0.78